Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion type Assertion NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_head.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion description "[In order to extend our knowledge on the expression and significance of CD44 in cells of the dispersed neuroendocrine system we investigated a spectrum of 134 neuroendocrine tumors, including pituitary adenomas, medullary thyroid carcinomas, parathyroid adenomas, pheochromocytomas, neuroblastomas, small-cell lung carcinomas, and bronchopulmonary, pancreatic, and gastrointestinal neuroendocrine tumors immunohistochemically for CD44 standard and variant exon-encoded gene products (CD44v3, -v4, -v5, -v6, -v9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_provenance.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion evidence source_evidence_literature NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_provenance.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion SIO_000772 8985743 NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_provenance.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion wasDerivedFrom befree-20140225 NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_provenance.
- NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_assertion wasGeneratedBy ECO_0000203 NP623386.RAjgahDNDp19HCR8aXDDQRQrevhvyv8wwBePdvADuYAtE130_provenance.